Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Jinhai International Group Holdings Limited ( (HK:2225) ) has provided an update.
Jinhai Medical Technology Limited has announced significant changes in its board of directors, with the appointment of Mr. Jiang Jiangyu as a non-executive director and vice chairman, effective January 28, 2025. Mr. Jiang brings extensive experience in information technology and business management to the company. Concurrently, Mr. Dai Yong has resigned from his position as an executive director to pursue other business commitments. These leadership changes are expected to influence the company’s strategic direction and operations, potentially impacting its position and performance in the medical technology industry.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited is a company incorporated in the Cayman Islands, operating within the medical technology sector. The company and its subsidiaries focus on providing innovative medical solutions, enhancing healthcare services, and contributing to advancements in medical technology.
YTD Price Performance: -29.47%
Average Trading Volume: 4,380,064
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$6.93B
See more insights into 2225 stock on TipRanks’ Stock Analysis page.
